Escitalopram and progressive muscle relaxation training are both effective for the treatment of hot flashes in patients with breast cancer: a randomized controlled trial

References

• Ferlay J, Soerjomataram I, Ervik M, et al. Lyon, France: international agency for research on cancer. Cancer Incidence a Mortal Worldwide: IARC Cancer Base. 2012;11:2013.
   Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
   PubMed Web of Science ®Google Scholar
• Clarke M, Collins R, Darby S, et al. Early breast cancer trialists collaborative group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–2106.
   PubMed Web of Science ®Google Scholar
• Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–1716.
   PubMed Web of Science ®Google Scholar
• Jatoi I, Miller AB. Why is breast-cancer mortality declining? Lancet Oncol. 2003;4(4):251–254.
   PubMed Web of Science ®Google Scholar
• Knobf MT. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors. The Oncologist. 2006;11(2):96–110.
   PubMed Web of Science ®Google Scholar
• Antoine C, Vandromme J, Fastrez M, et al. A survey among breast cancer survivors: treatment of the climacteric after breast cancer. Climacteric. 2008;11(4):322–328.
   PubMed Web of Science ®Google Scholar
• Biglia N, Cozzarella M, Cacciari F, et al. Menopause after breast cancer: a survey on breast cancer survivors. Maturitas. 2003;45(1):29–38.
   PubMed Web of Science ®Google Scholar
• Hickey M, Saunders C, Partridge A, et al. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol. 2008;19(10):1669–1680.
   PubMed Web of Science ®Google Scholar
• Freedman RR. Hot flashes: behavioral treatments, mechanisms, and relation to sleep. Am J Med. 2005;118 Suppl 12B(12):124–130.
   PubMed Web of Science ®Google Scholar
• de Zambotti M, Colrain IM, Javitz HS, et al. Magnitude of the impact of hot flashes on sleep in perimenopausal women. Fertil Steril. 2014;102(6):1708–1715.
   PubMed Web of Science ®Google Scholar
• Erlik Y, Tataryn IV, Meldrum DR, et al. Association of waking episodes with menopausal hot flushes. JAMA. 1981;245(17):1741–1744.
   PubMed Web of Science ®Google Scholar
• MacLennan AH, Broadbent JL, Lester S, et al. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;4: CD002978.
   PubMedGoogle Scholar
• Heiss G, Wallace R, Anderson GL, et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008;299(9):1036–1045.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA. 2002;288(3):321–333.
   PubMed Web of Science ®Google Scholar
• Holmberg L, Iversen O-E, Rudenstam CM, et al. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst. 2008;100(7):475–482.
   PubMedGoogle Scholar
• Sismondi P, Kimmig R, Kubista E, et al. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients—data from LIBERATE trial. Maturitas. 2011;70(4):365–372.
   PubMed Web of Science ®Google Scholar
• ACOG practice bulletin no. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123(1):202–216.
   PubMed Web of Science ®Google Scholar
• Sassarini J, Lumsden MA. 2013. Non-hormonal management of vasomotor symptoms. Taylor & Francis.
   Google Scholar
• Barton DL, LaVasseur BI, Sloan JA, et al. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol. 2010;28(20):3278–3283.
   PubMed Web of Science ®Google Scholar
• Dobkin RD, Menza M, Allen LA, et al. Escitalopram reduces hot flashes in non-depressed menopausal women: a pilot study. Ann Clin Psychiatry. 2009;21(2):70.
   PubMed Web of Science ®Google Scholar
• Freeman MP, Hirschberg AM, Wang B, et al. Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition. Maturitas. 2013;75(2):170–174.
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000;356(9247):2059–2063.
   PubMed Web of Science ®Google Scholar
• Simon JA, Portman DJ, Kaunitz AM, et al. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials. Menopause. 2013;20(10):1027–1035.
   PubMed Web of Science ®Google Scholar
• Shams T, Firwana B, Habib F, et al. SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials. J Gen Intern Med. 2014;29(1):204–213.
   PubMed Web of Science ®Google Scholar
• Biglia N, Bounous VE, Susini T, et al. Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivors. Eur J Cancer Care. 2018;27(1):e12484.
   Web of Science ®Google Scholar
• Fugate SE, Church CO. Nonestrogen treatment modalities for vasomotor symptoms associated with menopause. Ann Pharmacother. 2004;38(9):1482–1499.
   PubMed Web of Science ®Google Scholar
• Boekhout AH, Vincent AD, Dalesio OB, et al. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2011;29(29):3862–3868.
   PubMed Web of Science ®Google Scholar
• Kent JM. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet. 2000;355(9207):911–918.
   PubMed Web of Science ®Google Scholar
• Aguglia E, Ravasio R, Simonetti M, et al. Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003–2009. Curr Med Res Opin. 2012;28(9):1475–1484.
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. Non-hormonal management of menopause-associated vasomotor symptoms: 2015 position statement of the North American Menopause Society. Menopause. 2015;22(11):1155–1172.
   PubMed Web of Science ®Google Scholar
• Szabo RA, Marino JL, Hickey M. Managing menopausal symptoms after cancer. Climacteric. 2019;22(6):572–578.
   PubMed Web of Science ®Google Scholar
• Molassiotis A, Yung HP, Yam BM, et al. The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial. Support Care Cancer. 2002;10(3):237–246.
   PubMed Web of Science ®Google Scholar
• Shell GA, Kirsch S. Psychosocial issues, outcomes and quality of life. Oncol Nurs. 2001;4:948–970.
   Google Scholar
• Wright S, Courtney U, Crowther D. A quantitative and qualitative pilot study of the perceived benefits of autogenic training for a group of people with cancer. Eur J Cancer Care. 2002;11(2):122–130.
   PubMed Web of Science ®Google Scholar
• Hunter M. Cognitive behavioural interventions for premenstrual and menopausal symptoms. J Reprod Infant Psychol. 2003;21(3):183–193.
   Web of Science ®Google Scholar
• Hunter MS, Liao KL. Evaluation of a four‐session cognitive–behavioural intervention for menopausal hot flushes. Br J Health Psychol. 1996;1(2):113–125.
   Web of Science ®Google Scholar
• Lindh-Åstrand L, Nedstrand E, Wyon Y, et al. Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy. Maturitas. 2004;48(2):97–105.
   PubMed Web of Science ®Google Scholar
• McCallie MS, Blum CM, Hood CJ. Progressive muscle relaxation. J Human Behav Soc Environ. 2006;13(3):51–66.
   Google Scholar
• Park S, Song C, Oh Y-A, et al. Comparison of physiological and psychological relaxation using measurements of heart rate variability, prefrontal cortex activity, and subjective indexes after completing tasks with and without foliage plants. Int J Environ Res Public Health. 2017;14(9):1087.
   PubMed Web of Science ®Google Scholar
• Jacobson E. Progressive muscle relaxation. J Abnorm Psychol. 1938;75(1):18.
   Google Scholar
• Heinemann LAJ, Potthoff P, Schneider HPG. International versions of the menopause rating scale (MRS). Health Qual Life Outcomes. 2003;1(1):28.
   PubMedGoogle Scholar
• Nazarpour S, Simbar M, Ramezani Tehrani F. Effects of the severity of menopausal symptoms on sexual function in postmenopausal women TT – تأثیر شدت نشانه‌های یائسگی بر عملکرد جنسی زنان یائسه. JQUMS. 2015;19(4):54–63.
   Google Scholar
• Faul F, Erdfelder E, Buchner A, et al. Statistical power analyses using G* power 3.1: tests for correlation and regression analyses. Behavior Res Methods. 2009;41(4):1149–1160.
   PubMed Web of Science ®Google Scholar
• Grady D. Clinical practice. Management of menopausal symptoms. N Engl J Med. 2006;355(22):2338–2347.
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. The 2012 hormone therapy position statement of the North American Menopause Society. Menopause. 2012;19(3):257.
   PubMed Web of Science ®Google Scholar
• Reed SD, Ludman EJ, Newton KM, et al. Depressive symptoms and menopausal burden in the midlife. Maturitas. 2009;62(3):306–310.
   PubMed Web of Science ®Google Scholar
• Fann JR, Thomas-Rich AM, Katon WJ, et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 2008;30(2):112–126.
   PubMed Web of Science ®Google Scholar
• Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J-Med Assoc Thailand. 2007;90(10):2164.
   PubMedGoogle Scholar
• Freeman EW, Guthrie KA, Caan B, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA. 2011;305(3):267–274.
   PubMed Web of Science ®Google Scholar
• Soares CN, Arsenio H, Joffe H, et al. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri-and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause. 2006;13(5):780–786.
   PubMed Web of Science ®Google Scholar
• Fenlon DR, Corner JL, Haviland JS. A randomized controlled trial of relaxation training to reduce hot flashes in women with primary breast cancer. J Pain Symptom Manage. 2008;35(4):397–405.
   PubMed Web of Science ®Google Scholar
• Irvin JH, Domar AD, Clark C, et al. The effects of relaxation response training on menopausal symptoms. J Psychosom Obstetr Gynec. 1996;17(4):202–207.
   PubMed Web of Science ®Google Scholar
• Demiralp M, Oflaz F, Komurcu S. Effects of relaxation training on sleep quality and fatigue in patients with breast cancer undergoing adjuvant chemotherapy. J Clin Nurs. 2010;19(7-8):1073–1083.
   PubMed Web of Science ®Google Scholar
• Cohen M, Fried G. Comparing relaxation training and cognitive-behavioral group therapy for women with breast cancer. Research on Social Work Practice. 2007;17(3):313–323.
   Web of Science ®Google Scholar
• Cascade E, Kalali AH, Kennedy SH. Real-world data on SSRI antidepressant side effects. Psychiatry. 2009;6(2):16–18.
   PubMedGoogle Scholar